FDA Approved Medical Products for:

Gastrointestinal Stromal Tumors

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Imatinib mesylate
Trade Name
(Manufacturer Name)
Gleevec®
(Novartis Pharmaceuticals Corp.)
Indication
The FDA has approved this product to be used in this manner.
Treatment of patients with Kit (CD117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumors (GIST)
More Information about this product Drug Information Portal

Generic Name Regorafenib
Trade Name
(Manufacturer Name)
Stivarga
(Bayer HealthCare Pharmaceuticals, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Treatment of patients with locally advanced, unresectable or metastatic gastrointestinal stromal tumor (GIST) who have been previously treated with imatinib mesylate and sunitinib malate.
More Information about this product Drug Information Portal
Medline Plus Health Information

Generic Name Pazopanib
Trade Name
(Manufacturer Name)
Votrient
(GlaxoSmithKline)
Indication
The FDA has approved this product to be used in this manner.
Advanced soft tissue sarcoma (STS) who have received prior chemotherapy.
More Information about this product Drug Information Portal
Medline Plus Health Information